Company Filing History:
1 out of 230 
1 out of 15 
1 out of 1,745 
Years Active: 2022
Title: Marie Nollet: Innovator in Cancer Treatment
Introduction
Marie Nollet is a prominent inventor based in Fréjus, France. She has made significant contributions to the field of cancer diagnostics and treatment. Her innovative work focuses on the development of antibodies that target specific tumors, providing new avenues for cancer therapy.
Latest Patents
Marie Nollet holds a patent for "Anti-CD146 antibodies and uses thereof." This invention relates to the diagnosis and treatment of various cancers, including melanoma, pancreatic cancer, kidney cancer, and colon cancer. The patent describes an antibody specifically directed at CD146-positive tumors, which can be utilized as a medicament for cancer prevention and treatment. Additionally, it can serve in diagnostic or prognostic methods for cancer or as a radiotracer when labeled with a radioactive element.
Career Highlights
Throughout her career, Marie has worked with esteemed institutions such as Université d'Aix-Marseille and Assistance Publique—Hôpitaux de Marseille. Her research has been pivotal in advancing the understanding and treatment of cancer, showcasing her dedication to improving patient outcomes.
Collaborations
Marie has collaborated with notable colleagues, including Marcel Blot-Chabaud and Benjamin Guillet. These partnerships have enriched her research and contributed to the success of her innovative projects.
Conclusion
Marie Nollet's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. Her patented inventions and collaborations highlight her commitment to advancing healthcare solutions.